The European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study is part of the largest prospective evaluation of diet and health ever undertaken. The entire EPIC study involves ...
—Elevated HDL-C has been seen as protection from CVD. But this study, conducted in patients with CAD, seems to confirm other studies showing that in addition to low HDL-C levels (≤ 30 mg/dL), a very ...
Expert Rev Cardiovasc Ther. 2010;8(3):345-358. © 2010 Expert Reviews Ltd. Cite this: Implications of Torcetrapib Failure for the Future of HDL Therapy: Is HDL ...
We all know that it’s important to control your cholesterol, but the focus tends to be on the so-called “bad cholesterol” or LDL cholesterol. For most folks, their “good cholesterol” or HDL ...
Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
BOSTON, April 30, 2004 – Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride ...
One reason some people live into their 90s and beyond may be a genetic variation that makes the cholesterol particles in their blood really big. “Supersize it” is not usually associated with good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results